Pages that link to "Q38350833"
Jump to navigation
Jump to search
The following pages link to Antibody-mediated targeting of liposomes to red cells in vivo (Q38350833):
Displaying 13 items.
- Tuftsin-bearing liposomes in treatment of macrophage-based infections. (Q33852973) (← links)
- Immunoliposomes for the targeted delivery of antitumor drugs (Q33933508) (← links)
- Chloroquine encapsulated in malaria-infected erythrocyte-specific antibody-bearing liposomes effectively controls chloroquine-resistant Plasmodium berghei infections in mice. (Q35111086) (← links)
- Targeted erythropoietin selectively stimulates red blood cell expansion in vivo (Q36905103) (← links)
- Erythrocytes-based synthetic delivery systems: transition from conventional to novel engineering strategies (Q38218799) (← links)
- Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers (Q38689437) (← links)
- Cancer chemotherapy administered by activated carbon particles and liposomes (Q38737462) (← links)
- Biopharmaceutics of microparticulate drug carriers (Q39696536) (← links)
- A nanovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus non-infected red blood cells in vitro (Q39966170) (← links)
- Liposomal delivery of a phosphodiesterase 3 inhibitor rescues low oxygen-induced ATP release from erythrocytes of humans with type 2 diabetes (Q43499334) (← links)
- On the interaction of the liposomal membrane with blood components (Q45233532) (← links)
- Pharmacokinetics and chemotherapeutic efficacy of adriamycin encapsulated in immunoliposomes against avian myeloblastosis virus infection (Q45832191) (← links)
- Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes. (Q54941595) (← links)